Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy
Walter, Eva, Schmitt,, Thomas, Dietrich, Sascha, Ho, Anthony, Witzens-Harig, MathiasVolume:
53
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2012.682311
Date:
November, 2012
File:
PDF, 150 KB
english, 2012